ICN PHARMACEUTICALS, INC. — TTAB Proceedings
ICN PHARMACEUTICALS, INC. is a party to 9 TTAB proceedings.
Proceedings
- Proceeding 78328420 — Extensions of Time to Oppose, Terminated (filed 2005-11-23) against SCHERING CORPORATION as defendant
- Proceeding 91156039 — Oppositions, Terminated (filed 2003-03-24) against Andrx Pharmaceuticals, Inc. as plaintiff
- Proceeding 78136539 — Extensions of Time to Oppose, Terminated (filed 2003-01-06) against Andrx Pharmaceuticals, Inc. as plaintiff
- Proceeding 78136539 — Extensions of Time to Oppose, Terminated (filed 2003-01-06) against Andrx Pharmaceuticals, Inc. as plaintiff
- Proceeding 78102631 — Extensions of Time to Oppose, Terminated (filed 2002-11-19) against Glaxo Group Limited as defendant
- Proceeding 91123754 — Oppositions, Terminated (filed 2001-07-30) against BRISTOL-MYERS SQUIBB COMPANY as defendant
- Proceeding 78105563 — Extensions of Time to Oppose, Terminated (filed 2002-08-21) against Glaxo Group Limited as defendant
- Proceeding 91099394 — Oppositions, Terminated (filed 1995-08-18) against CLEMENT PAPPAS AND COMPANY, INC. as plaintiff
- Proceeding 91079422 — Oppositions, Terminated (filed 1988-11-28) against DAGHIGH SOFTWARE COMPANY, INC., D.B.A. INTERNATIONAL COMPUTER NETWORKS as plaintiff
Marks in These TTAB Matters
- RIBAPHARM — proceeding 78328420 (Defendant)
- ADENAZOLE — proceeding 91156039 (Plaintiff)
- ADENAZOLE — proceeding 78136539 (Plaintiff)
- HEPAVIR B — proceeding 78102631 (Defendant)
- HEPAVIR C — proceeding 78105563 (Defendant)
- TIAZOLE — proceeding 91123754 (Defendant)
- KIST — proceeding 91099394 (Plaintiff)
- ICN — proceeding 91079422 (Plaintiff)
Common TTAB Counterparties
- Andrx Pharmaceuticals, Inc. — 2 proceedings
- Glaxo Group Limited — 2 proceedings
- BRISTOL-MYERS SQUIBB COMPANY — 1 proceedings
- CLEMENT PAPPAS AND COMPANY, INC. — 1 proceedings
- DAGHIGH SOFTWARE COMPANY, INC., D.B.A. INTERNATIONAL COMPUTER NETWORKS — 1 proceedings
- SCHERING CORPORATION — 1 proceedings
Recent TTAB Timeline
- 2005-11-23: 78328420 — EXTENSION OF TIME GRANTED involving SCHERING CORPORATION
- 2005-11-23: 78328420 — INCOMING - EXT TIME TO OPPOSE FILED involving SCHERING CORPORATION
- 2003-11-04: 91156039 — TERMINATED involving Andrx Pharmaceuticals, Inc.
- 2003-08-11: 91156039 — BOARD'S DECISION: SUSTAINED involving Andrx Pharmaceuticals, Inc.
- 2003-04-22: 91156039 — PENDING, INSTITUTED involving Andrx Pharmaceuticals, Inc.
- 2003-04-22: 91156039 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving Andrx Pharmaceuticals, Inc.
- 2003-03-24: 91156039 — FILED AND FEE involving Andrx Pharmaceuticals, Inc.
- 2003-03-09: 78136539 — EXTENSION OF TIME GRANTED involving Andrx Pharmaceuticals, Inc.
- 2003-03-09: 78136539 — EXTENSION OF TIME GRANTED involving Andrx Pharmaceuticals, Inc.
- 2003-02-21: 78136539 — INCOMING - EXT TIME TO OPPOSE FILED involving Andrx Pharmaceuticals, Inc.
- 2003-02-21: 78136539 — INCOMING - EXT TIME TO OPPOSE FILED involving Andrx Pharmaceuticals, Inc.
- 2003-01-21: 78136539 — EXTENSION OF TIME GRANTED involving Andrx Pharmaceuticals, Inc.
- 2003-01-21: 78136539 — EXTENSION OF TIME GRANTED involving Andrx Pharmaceuticals, Inc.
- 2003-01-16: 78136539 — INCOMING - EXT TIME TO OPPOSE FILED involving Andrx Pharmaceuticals, Inc.
- 2003-01-16: 78136539 — INCOMING - EXT TIME TO OPPOSE FILED involving Andrx Pharmaceuticals, Inc.
- 2003-01-06: 78102631 — SUBMITTED ON BRIEF involving Glaxo Group Limited
- 2003-01-06: 78136539 — EXTENSION OF TIME GRANTED involving Andrx Pharmaceuticals, Inc.
- 2003-01-06: 78136539 — EXTENSION OF TIME GRANTED involving Andrx Pharmaceuticals, Inc.
- 2003-01-06: 78136539 — INCOMING - EXT TIME TO OPPOSE FILED involving Andrx Pharmaceuticals, Inc.
- 2003-01-06: 78136539 — INCOMING - EXT TIME TO OPPOSE FILED involving Andrx Pharmaceuticals, Inc.
- 2002-11-19: 78102631 — EXTENSION OF TIME GRANTED involving Glaxo Group Limited
- 2002-11-19: 78102631 — EXTENSION OF TIME GRANTED involving Glaxo Group Limited
- 2002-11-08: 78102631 — ABANDONED AFTER PUBLICATION involving Glaxo Group Limited
- 2002-11-08: 78105563 — EXPRESS ABANDONMENT OF APPLICATION involving Glaxo Group Limited
- 2002-10-21: 78102631 — INCOMING - EXT TIME TO OPPOSE FILED involving Glaxo Group Limited
- 2002-10-10: 78105563 — SUBMITTED ON BRIEF involving Glaxo Group Limited
- 2002-10-07: 91123754 — TERMINATED involving BRISTOL-MYERS SQUIBB COMPANY
- 2002-10-07: 91123754 — BOARD'S DECISION: SUSTAINED involving BRISTOL-MYERS SQUIBB COMPANY
- 2002-08-21: 78105563 — EXTENSION OF TIME GRANTED involving Glaxo Group Limited
- 2002-08-15: 78105563 — INCOMING - EXT TIME TO OPPOSE FILED involving Glaxo Group Limited